_version_ 1784615180842303488
collection PubMed
description
format Online
Article
Text
id pubmed-8671645
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-86716452021-12-15 Editor's Note Int J Antimicrob Agents Article Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2022-01 2021-12-15 /pmc/articles/PMC8671645/ /pubmed/34920914 http://dx.doi.org/10.1016/j.ijantimicag.2021.106494 Text en © 2021 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Editor's Note
title Editor's Note
title_full Editor's Note
title_fullStr Editor's Note
title_full_unstemmed Editor's Note
title_short Editor's Note
title_sort editor's note
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671645/
https://www.ncbi.nlm.nih.gov/pubmed/34920914
http://dx.doi.org/10.1016/j.ijantimicag.2021.106494